See how a robotic-assisted innovation could help with knee-replacement surgery
Over three million people have knee-replacement surgery each year. The VELYSTM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.
Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
Cell therapy is bringing the world one step closer to eliminating cancer. Here’s how Johnson & Johnson has treated more than 10,000 patients and counting with this cutting-edge therapy.